Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shahzad Malik currently holds 4,022 shares of Iterum Therapeutics plc (ITRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shahzad Malik has been a net seller of ITRM stock. They have purchased $7.4M and sold $19.8M worth of shares.
Shahzad Malik's most recent insider trade was on Jun 17, 2021, when they sold 1,800 shares at $0.00 per share.
Shahzad Malik serves as Executive at Iterum Therapeutics plc (ITRM). They have executed 41 insider transactions totaling $27.2M over their tenure at the company.
Shahzad Malik holds the position of Executive at Iterum Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Shahzad Malik has shown a selling trading pattern, with $7.4M in total purchases and $19.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shahzad Malik was on May 27, 2015, when they sold $10.0M worth of AGEN shares. This transaction involved 1,587,302 shares at $6.30 per share.
Shahzad Malik currently owns 4,022 shares of Iterum Therapeutics plc (ITRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shahzad Malik's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shahzad Malik has 41 Form 4 filings on record as an insider at Iterum Therapeutics plc.
Set alerts for Shahzad Malik and 40,000+ other insiders.